VELOXIS PHARMACEUTICALS A/S: Financial statements 2018
CVR: 26527767
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
VELOXIS PHARMACEUTICALS A/S (CVR 26527767) has filed annual accounts for 2018. In 2018, the company reported revenue of USD 39,494,000 and a net result of USD -5,285,000 compared with USD -9,542,000 the year before. That is an increase of 30.9% compared with the year before. The profit margin was -13.4%. Equity in the 2018 report amounted to USD 4,614,000. The solvency ratio was 6%.
- Revenue
- USD 39,494,000
- Gross Profit
- USD 31,576,000
- Profit/Loss
- USD -5,285,000
- Equity
- USD 4,614,000
- Total Assets
- USD 77,117,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 39.5M USD | 31.6M USD | -5.3M USD | 4.6M USD | - |
| 2017 | 30.2M USD | 25M USD | -9.5M USD | 5.3M USD | - |
| 2016 | 9.2M USD | 6.2M USD | -10.1M USD | 10.2M USD | - |
| 2015 | 14.2M | -989K | -176.1M | 89.7M | - |
| 2014 | 123.4M | 120.1M | -36.3M | 253.2M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
VELOXIS PHARMACEUTICALS A/S has published its interim report for the period January 1, 2018 to September 30, 2018.
As of October 31, 2018, Ira Duarte is registered as director of VELOXIS PHARMACEUTICALS A/S.
As of September 24, 2018, Morten Marott has stepped down as director of VELOXIS PHARMACEUTICALS A/S.
VELOXIS PHARMACEUTICALS A/S has published its interim report for the period January 1, 2018 to June 30, 2018.
VELOXIS PHARMACEUTICALS A/S has published its interim report for the period January 1, 2018 to March 31, 2018.
VELOXIS PHARMACEUTICALS A/S has published its annual report for 2017. Revenue came to DKK 30,167,000, and the net result was DKK -9,542,000.
As of April 3, 2018, Morten Marott is registered as director of VELOXIS PHARMACEUTICALS A/S.
About VELOXIS PHARMACEUTICALS A/S
VELOXIS PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Nordhavn, founded in 2002. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named LIFECYCLE PHARMA A/S and PHAROTECH A/S. The management consists of Daisuke Matsuo. The board consists of Keigo Nakatsukasa (chair), Daisuke Matsuo and Kenro Yuzaki. The company is owned by Asahi Kasei Corporation. The company has 1 employee (2022). In 2026, the company reported a net result of DKK -1,553,000. Equity in the 2026 report amounted to DKK 611,587,000.